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Abstract
The first version of this article appeared on the Social Science Research Network more than five years ago. At
the time, Andrea Carska-Sheppard, Paul Weiler, and Jim Medford suggested an interdisciplinary debate to
bring about solutions urgently needed in the area of performance enhancing malpractice in sports. This was
before the Congressional investigations on steroid use, which brought public scrutiny to professional sports.
While our society deals (with varying success) with other types of offenses by providing perpetrators with
means of support and rehabilitation, we noted there is very little systematic support available to athletes who
are suspended for performance enhancing malpractice. The article offered a debate on the legal model that
would provide corrective justice and rehabilitation for these types of wrongdoing. In order to create a legal
model the authors turned to Professor Weiler’s proposed medical malpractice theory and applied it to
performance enhancing malpractice. The World Antidoping Agency (WADA) has now adopted its revised
Anti-Doping Code and the time has come to revisit our article and the proposed model. What the authors
found is that, despite of the passage of time, their proposal is still timely and calls for the attention of all
stakeholders. Though the new Anti-Doping Code sheds light on various aspects of doping prosecution and
education, it is silent as to the rehabilitation and assistance provision to athletes implicated in doping. The
concept of offering a systematic assistance model to the wrongdoers relates to the morality of current and
future generations, which cannot be ignored. Instead it is time for the stakeholders to review and examine the
model proposed in this article, which would assist athletes and enhance corrective principals in doping
malpractice management.
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Back on Track 2:  The Principles of Corrective Justice 
for Performance Enhancing Malpractice in Sports 
 
Andrea Carska-Sheppard, Paul Weiler, Jim Medford
1
 
 
I. Introduction 
The first version of this article appeared on the Social Science Research Network more 
than five years ago.
2
 At the time, we suggested an interdisciplinary debate to bring about 
solutions urgently needed in the area of performance enhancing malpractice in sports.  This was 
before the Congressional investigations on steroid use
3
 which brought public scrutiny to 
professional sports. 
When we analyzed the issue of performance enhancing malpractice, we noted new 
angles, which required analysis of, and attention to, the legal sport community and society in 
general. The time had come to focus not only on the prosecution of athletes implicated in doping 
offenses but to analyze their needs and provide a corrective model.  
While our society deals (with varying success) with other types of offenses by providing 
perpetrators with means of support and rehabilitation, we noted there is very little systematic 
support available to athletes who are suspended for performance enhancing malpractice.  The 
article offered a debate on the legal model that would provide corrective justice and 
rehabilitation for these types of wrongdoing.   In order to create a legal model we have turned to 
Professor Weiler’s proposed medical malpractice theory and applied it to performance enhancing 
malpractice.    
                                                     
1
 The contacts for the authors are: andrea.carska-sheppard@smithmoorelaw.com; pweiler@law.harvard.edu; 
jim.medford@smithmoorelaw.com. The views expressed reflect the views of the authors alone. 
2
Andrea Carska-Sheppard, Paul Weiler and Jim Medford, Back on Track: The Principles of Corrective Justice for 
Performance Enhancing Malpractice in Sports, SSRN.COM (Oct. 27, 2007), 
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1020302. 
3
 Jeff Passan, Palmeiro’s Shameful End, YAHOO! SPORTS, http://sports.yahoo.com/mlb/news?slug=jp-
palmeiro080106 (last visited Mar. 17, 2012). 
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There is no doubt that, just like several years ago, the subject matter of performance 
enhancing malpractice ignites opposing reactions.  As a society, we feel morally reluctant to 
offer help to those who compete unfairly.  On the other hand, we recognize the fact that a doping 
control system is not error-proof, and that suspended athletes need support and another chance. 
The World Antidoping Agency (WADA) has now adopted its revised Anti-Doping Code 
and the time has come to revisit our article and the proposed model. What we found is that, 
despite of the passage of time, our proposal is still timely and calls for the attention of all 
stakeholders. Though the new Anti-Doping Code sheds light on various aspects of doping 
prosecution and education, it is silent as to the rehabilitation and assistance provision to athletes 
implicated in doping.   
As this insightful comments states “ [a]thletes who have been suspended from their sport, 
even after presenting evidence that the supplements that they were taking were contaminated, 
suffer tremendously. They are prevented from participating in their sport, often for a lengthy 
period of time, costing them sums of money in the form of lost salary, lost prize money, and lost 
endorsements.”4 
The concept of offering a systematic assistance model to the wrongdoers relates to the 
morality of current and future generations, which cannot be ignored.  Instead, as we look forward 
to London and many other sporting events, it is a good time for the stakeholders to review and 
examine the model we are proposing in this article, which would assist athletes and enhance 
corrective principals in doping malpractice management.  
 
                                                     
4
 Howard J. Jacobs, Athlete Lawsuits Against Supplement Companies Following Positive Drug Tests, ALI-ABA 
Course Materials, Course Number SP016, 1 (2009) [hereinafter Jacobs].  
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II. The Strict Liability Standard for Doping  
The arbitration of doping offenses is a game in which athletes never wish to participate.  
However, if by choice or circumstance they take the stage in this process, they will find 
themselves on complex legal grounds. The doping offenses dispute resolution system has been 
criticized for its lack of fairness.
5
  
One of the most contentious issues in sports arbitration remains the applicable standard of 
proof.  The root of this uncertainty stems from what standard of proof to use. Ultimately, this is 
due to an apparent inability to determine the nature of doping offenses.  Are these criminal, 
quasi-criminal or purely civil in nature?  Academics question whether this standard of proof 
should fall closer to proof beyond a reasonable doubt, because doping cases are, at the least, 
quasi-criminal in nature. Indeed, some may advocate for the preponderance of the evidence 
standard because doping cases are private in nature.
6
   
However, “most sport drug testing applies a strict liability standard of one form or 
another.”7 What the strict liability standard means is that “that an anti-doping rule violation 
occurs whenever a prohibited substance (or its metabolites or markers) is found in the bodily 
specimen of an athlete, whether or not the athlete intentionally or unintentionally used a 
prohibited substance or was negligent or otherwise at fault.”8 Unlike the negligence standard, the 
strict liability does not distinguish between the presence or absence of fault on the part of the 
defendant.  As the critics pointed out, the use of strict liability goes against the notion that a 
“cheater” must have requisite intent and “the system to catch cheaters, which disregards intent, is 
                                                     
5
  Michael Straubel, Enhancing the Performance of the Doping Court: How the Court of Arbitration for Sport Can 
Do Its Job Better, 36 Loy. U. Chi. L.J. 1203, 1259-1260 (2005). 
6
 Id. 
7
 Jacobs at 2.  
8
 Anti-Doping Glossary, WADA-AMA (Oct. 2011), http://www.wada-ama.org/en/Resources/Anti-Doping-Glossary/. 
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destined to sweep up many innocent individuals in its path.”9 Despite all criticism, the strict 
liability was found to be consistent with internationally recognized human rights and general 
principles
10
 and survived the global consultation process which reviewed the original WADC 
(“World Anti-Doping Code” and became part of the Revised World Anti-Doping Code which 
became effective as of January 1, 2009.
11
 
Scholars of tort law know that strict liability is at least as old as Rylands v. Fletcher.
12
  
The proponents of the strict liability theory see it as less messy than the additional showing of 
fault required in negligence cases. While negligence may appear equitable for showing the 
athlete’s fault, there are practical problems in proving negligence in certain cases.  “If plaintiffs 
experience systematic problems in their efforts to establish fault on the part of defendants – 
perhaps because of the loss or unavailability of evidence –defendants as a class will experience 
insufficient levels of liability.”13 One can see that it was largely for these practical reasons why 
the strict liability standard is applied in the doping offenses and it is a more efficient solution.  
Some strict liability statutes (E.g. for custodians of wild and domesticated animals) are 
written broadly to impose liability, irrespective of the owner’s prior knowledge, and some are 
less stringent.  Likewise, in the doping world, there was an attempt to find a balance by 
moderating an impact of strict liability standard of Article 2.1.1 by bringing the standards of  “no 
                                                     
9
 Jessica K. Foschi, Note: A Constant Battle: The evolving challenges in the international fight against doping in 
sports, 16 Duke J. Comp. & Int'l L. 457, 485-486 (2006). 
10
 Id. at 477.  
11
 WADA Consultation Process, WADA-AMA (July 2011) http://www.wada-
ama.org/en/dynamic.ch2?pageCategory.id=585 (The World Anti-Doping Code was first adopted in 2003 and 
became effective in 2004. The revisions to the World Anti-Doping Code that were approved by the World Anti-
Doping Agency Foundation Board on November 17, 2007. The revised World Anti-Doping Code became effective 
on January 1, 2009).  
12
 Rylands v. Fletcher, 3 H. & C. 774, 159 Eng. Rep 737 (Ex. 1868).  
13
 JAMES A. HENDERSON, RICHARD N. PEARSON, & JOHN A. SOLICIANO, THE TORTS PROCESS 429 (Aspen 
Publishers, 6
th
 ed.) (2003). 
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fault”,  “no significant fault” or “negligence” on an athlete’s part at the sentencing stage.  The 
Commentary of the WADC to Article 2.1.1 states:  
The strict liability rule for the finding of a Prohibited Substance in an Athlete's 
Sample, with a possibility that sanctions may be modified based on specified 
criteria, provides a reasonable balance between effective anti-doping enforcement 
for the benefit of all  "clean" Athletes and fairness in the exceptional circumstance 
where a Prohibited Substance entered an Athlete’s system through No Fault or 
Negligence or No Significant Fault or Negligence on the Athlete’s part.  It is 
important to emphasize that while the determination of whether the anti-doping rule 
violation has occurred is based on strict liability, the imposition of a fixed period of 
Ineligibility is not automatic. The strict liability principle set forth in the Code has 
been consistently upheld in the decisions of CAS.
14
 
 
However, as the sentencing Article 10.5 WADC, which deals with the elimination or 
deduction of period of ineligibility, states it is only in “truly exceptional circumstances” and “not 
in the vast majority of the cases” when this Article is operative.  As such, its impact is 
constrained to very rare cases.  For example, a total exoneration of the athlete would occur when 
the athlete can show “that, despite all due care, he or she was sabotaged by a competitor.”15 
The defenses under Article 10.5 WADC will be raised whenever the circumstances of the 
cases so dictate. Whether the reduction in the ineligibility period will be applied on exceptional 
bases and very rare cases will depend, amongst others, on the quality of the testing procedures.  
Each year, an increasing number of athletes are tested by the WADA or by other sports bodies
16
, 
samples are contaminated, or the failure to follow proper testing procedures
17
 occurs. Despite the 
                                                     
14
 World Anti Doping Code, Art. 2.1.1 Commentary (2009), available at http://www.wada-
ama.org/Documents/World_Anti-Doping_Program/WADP-The-Code/WADA_Anti-Doping_CODE_2009_EN.pdf 
at 19 [hereinafter World Anti Doping Code]. 
15
  World Anti Doping Code, Art. 10.5.1 & 10.5.2 at 56-57. 
16
 2010 ANTI-DOPING ORGANIZATION ACTIVITY SUMMARY REPORTED BY CODE SIGNATORY ANTI-DOPING 
ORGANIZATIONS (2010), available at http://www.wada-
ama.org/Documents/Resources/Statistics/ADO_Statistics/WADA_2010_ADO_Statistics_Report.pdf  
17
 The CAS panel accepted that the supplemental contamination was likely the cause of the positive urine test.  See 
Knauss v. FIS, CAS, A/847 (Aust.– Switz.) (2005) (It took a professor of law and four third-year law students, all 
members of the Sports Law Clinic to succeed in representing a professional athlete whose doping test results were 
shown not be accurate and that scientific procedures were not followed by a testing lab. “Those factors led to a 
reduction of the otherwise applicable two-year suspension to 18 months.”).  
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best efforts to keep up with research on chemicals, steroids and highly speculative gene doping
18
, 
the performance enhancing control system for false negatives is not fully reliable.
19
 
 
III. Consequences of Doping Offenses  
   The WADC deals in great detail examining determination of culpability. It addresses 
issues of the sanctions for the individual and other stakeholders, the need for education to 
establish an environment that is strongly conducive to doping-free sport, but there is no guidance 
provided as to what, if any, assistance the individuals implicated in the doping offenses get.  In 
terms of the consequences of doping offenses, the WADC sets them out in regards to 
individuals
20
, the teams (e.g. target testing)
21
 and sanctions against sporting bodies.
22
 It also deals 
with the sanctions applicable to athlete support personnel to competent authorities. It provides 
for the mechanism to determine the period of ineligibility and the athlete’s status during period 
of ineligibility.  
An ineligible athlete cannot participate in a training camp, exhibition or practice 
organized by his or her National Federation or a club, which is a member of that Federation.
23
  It 
is also made explicit by the rules that “some or all sport-related financial support or other sport-
related benefits received by such Person athlete will be withheld by Signatories, Signatories' 
member organizations and governments.”24   
                                                     
18
 Paul D. Trumble, “Knickel” and Dime Issues: An Unexplored Loophole In New York’s Genetic Discrimination 
Statute And The Viability of Genetic Testing In the Sports Employment Context, 70 Alb. L. Rev. 771 (2007). 
19
 Ben Sellenger, Genetic Testing: The Future of Athlete Selection?, 2 Va. Sports & Ent. L.J. 207, 213 (2003) 
(warning of the "arbitrary application" of genetic testing in sports). 
20
 World Anti Doping Code, Art. 11 at 77.  
21
 World Anti Doping Code. Art. 12 at 78. . 
22
 World Anti Doping Code, Art. 10.10.1 at 74. 
23
 World Anti Doping Code, Art. 10.10.2 at 75-76.  
24
 World Anti Doping Code, Commentary Art. 10.10.3 at 75. 
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The athletes who are suspended may lose the support network that was created for them.  
A suspension rendered the athlete ineligible to have access to the training facilities of the USOC 
Training Centers or other programs and activities of the USOC, including grants and awards of 
employment.
25
  One of the clearer statements what happens to the suspended athletes after the 
adjudication, admission or acceptance of the doping offense is provided by the United States 
Olympic Committee (“USOC) Anti-Doping Polices in Annex C. 26  It is made explicit that the 
athlete loses the direct athlete support and, after the conclusion of the suspension, he/she will 
have to re-qualify for athlete support programs (e.g., attain appropriate rank, etc.).  The 
suspended athletes cannot be considered for a tuition grant during any period of suspension but if 
an athlete loses only the result, the tuition grant is maintained. First time violators of Section 
10.3 of the World Anti-Doping Code keep their access to the Olympic Training Center and 
Olympic Training Sites as well as the Olympic training center residence.  
First time violators keep their other USOC benefits, such as career consulting, access to 
the Athlete Service Center, media services, personal development programs, resource library 
access, sport science and coaching. What is less clear is to what extent the Athlete marketing 
services (including access to sponsor programs) are provided because, as stated on the website, 
“[p]articipation in the OJOP program and sponsor programs will also be dependent on employer 
or sponsor views” 27 which may result in a rather arbitrary standard. Elite Athletes, who are first 
time violators of Section 10.3 of the World Anti-Doping Code, do not lose the health insurance 
                                                     
25
 United States Anti-Doping Agency v. Mark Hainline, A.A.A. Case No. 30 190 00789 05 (2005) (Gans, Brunet, 
Witherspoon, Arb.). 
26
 Annex C To USOC National Anti-Doping Policies, TEAM USA, 
http://www.teamusa.org/resources/teamusanet/athlete-services/usoc-suspension-of-benefits-policy  (last visited Feb. 
8, 2012).  
27
 Id.  
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for the period of suspension. 
28
 The Elite Athlete program offers eligible athletes a level of base 
support by offering a program of health and major medical insurance for designated Elite 
Athletes in order to minimize the out-of-pocket expenses incurred by insured athletes for costs of 
medical care. 
29 
As is specified by the USOC under the World Anti-Doping Code, NGBs (“National 
Governing Bodies”), as members of a Code signatory (the USOC), must engage in the same or 
similar suspensions of benefits and access as the USOC.  NGBs are to adopt policies similar to 
those adopted by the USOC within this policy, subject to USOC approval.  There is very little 
systematic support provided to the athletes.  
Beyond the institutional impact, there are personal consequences to the athletes, who 
suffer emotionally and economically as a result of allegations/being implicated in the doping 
malpractice. In some, but not all cases, the arbitration costs are born by the athletes’ Olympic 
committee or federation.
30
 Those who have to finance their arbitration and lose leave the process 
morally condemned and financially depleted, facing the prospect of temporary or permanent 
unemployment, usually with very modest transferable skills.   To support their living, only a 
small group can rely on their personal savings and/or endorsement insurance.  The rest are left, to 
large extent, on their own to cope with moral stigma, little or no transferable skills, and no clear 
possibility for making a comeback. 
 
 
 
                                                     
28
 Id. 
29
 Elite Athlete Health Insurance Information (EAHI), TEAM USA, 
http://www.teamusa.org/resources/teamusanet/athlete-services/elite-athlete-health-insurance-information-eahi (last 
visited Feb. 8, 2012). 
30
 Id.  
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IV. Turning for Assistance  
Doping raises concerns not only in sports but in a social context as well.
31
  Numerous 
international instruments (i.e., the World Anti-Doping Code, the Athlete Outreach Model, 
32
 the 
Lausanne Declaration on Doping in Sport,
33
 and the International Convention Against Doping in 
Sport
34
) were developed to prevent and detect the problem of doping, but now we need to move a 
step further and recognize that the current doping control system needs not only to punish and 
deter but must also play a role in the rehabilitation of the athletes.  Unlike other wrongdoers, 
suspended athletes have no predictable support network and no counselors “on hand.”   
One of the forms of risk management in law and economics is insurance. It provides 
transfer of risk from one entity to another in exchange for the payment.  This raises question how 
the insurance industry deals with the performance enhancing malpractice in sports.  As we will 
show, the insurance companies have “strong policy reasons for limiting coverage in case of some 
intentional harm.”35 As such, how the individual insurers deal with the insurance contracts and 
how they can provide source of assistance for the athletes who have been involved in doping is a 
grey area. 
To start with, there are only a small number of companies that specialize in insurance 
products for athletes, such as K&K Insurance providers and Lloyds of London.  Given the high 
risks associated with sports and the susceptibility of the athletes to various types of injuries, this 
                                                     
31
 George W. Bush, President of the United States of America, State of the Union Address at a Joint Session of 
Congress (Jan. 20, 2004), transcript available at http://www.washingtonpost.com/wp-
srv/politics/transcripts/bushtext_012004.html (last visited Mar. 17, 2012).  In the 2004 State of the Union Address, it 
was mentioned that the use of performance-enhancing drugs, even in a minority of elite athletes, sets a dangerous 
example for the millions of young Americans.  
32
 Doping Lusanne Declaration (Feb. 4 1999), available at 
http://www.la84foundation.org/OlympicInformationCenter/OlympicReview/1999/OREXXVI25/OREXXVI25g.pdf  
33
 Adopted by the World Conference on Doping in Sport 4 February 1999, Lausanne, Switzerland.  
34
 Council of Europe Anti-Doping Convention No. 135, Nov. 16, 1989., S. TREATY DOC. NO. 110-14, E.T.S. 135; 
see also John R. Crook, United States Supports New UNESCO Instruments on Doping in Sports and on Bioethics; 
Votes Against New Convention on Cultural Diversity, 100 AM. J. INT’L L. 229 (2006). 
35
 TOM BAKER, INSURANCE, LAW AND POLICY 478 (Aspen Publishers, 1
st
 ed. 2003). 
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low concentration of insurance product providers is understandable.  The insurance coverage for 
athletes usually carries a high price tag.  In order to get coverage, the athletes must undergo 
intensive medical evaluations by both their teams and the insurance companies to determine the 
likelihood of having a predisposition to a particular illness, but even the athletes who are healthy 
and very successful have to pay enormous amounts to insure their contracts.
36
 Other than 
contract insurance, there are number of insurance products specifically designed for athletes and 
the sports industry; i.e.., Accidental Death and Dismemberment, Temporary Total Disability, 
Permanent Total Disability, Kidnap and Ransom, Image Protection, Critical Asset Protection, 
Contractual Bonus, Insurance programs for elite athletes, future earnings against injury, Personal 
Accident and Team Stop Loss.  Most of these insurance products are not specific about the 
coverage for athletes who are charged with being under the influence of drugs or narcotics that 
are not lawfully available.   
Further, it is also unclear which substances or methods listed on the WADA’s Prohibited 
List carry with themselves criminal penalties. 
37
 This is country-specific but creates difficulty for 
the insurers.  On the one hand there is an athlete who was charged by performance enhancing 
malpractice by an international body of law, on the other hand there is an insurance contract 
governed by chosen law and usually silent on exclusions for the performance enhancing 
malpractice.  The current process seems to be thus based more on the case-by-case 
determination. 
38
 
                                                     
36
 For example, Daniel Alfredsson would have to pay more than $1 million to insure his five-year, $32.5-million US 
deal with the Senators to play back home in Sweden.  
37
 World Anti-Doping Agency, The World Anti-Doping Code: The 2006 Prohibited List (Sept. 19, 2005), available 
at http://www.internationalgolffederation.org/MemberOnly/pdf/2%20-%202006%20Prohibited%20List.pdf 
(WADA’s Prohibited List includes the substances and methods that are prohibited: 1) at all times; 2) in competition; 
and 3) in particular sporting events. It also references so-called specialized substances).  
38
 The rumors of doping by Lance Armstrong were enough for SCA, a Texas Insurance company, to refuse to pay 
the six-time Tour de France winner the $5M bonus that became due to him when he broke the record for victories.  
At the initial stage, all the evidence the SCA had against him was circumstantial speculation by the authors of an 
2012] BACK ON TRACK 2 147 
 
 
This lack of interest and systematic assistance should raise serious concerns.  These 
individuals are treated differently than other vulnerable members of society who can rely on a 
support network provided by their community or their professional organizations. 
 
V. Professor Weiler’s Radically Moderate Correlative Model and Doping Malpractice  
In order to balance this imbalanced situation for these athletes in comparison with other 
wrongdoers, we need to inquire as to what can be done to bring these athletes back on track.  To 
better extrapolate this situation, we need to analyze it from the corrective justice point of view.   
Citing Aristotle, Professor Weinrib contrasts corrective justice with distributive justice.
39
   
While distributive justice is concerned with “proportional equality, in which all participants in 
the distribution receive their shares according to their respective merits under the criterion in 
question,” the corrective justice “features the maintenance and restoration of the notional 
equality with which the parties enter the transaction.” 40  It links the doer and sufferer of an 
injustice in terms of their correlative positions. 
41
    
When devising a reform model for medical malpractice, Professor Weiler adopted what 
he calls a radically moderate approach for examining the correlative positions of all the parties 
involved. In our first Back on Track 
42
 article, we introduced his reform proposal and examined 
                                                                                                                                                                           
unauthorized biography in France.  Ultimately, the SCA had to retract its premature exclusion and paid the bonus.  
However, this example shows how allegations of performance enhancement can prompt insurers to take adverse 
actions against athletes who have never been sanctioned. William Fotheringham, Insurers withhold $5m Tour bonus 
for Armstrong, THE GUARDIAN (Sept. 23, 2004), 
http://sport.guardian.co.uk/tourdefrance2004/story/0,14667,1310624,00.html.  
39
 Ernest J. Weinrib, Corrective Justice in a Nutshell, 52 U. Toronto L.J. 349 (2002). 
40
 Id.  
41
 Id. at 351. 
42
 Andrea Carska-Sheppard, Paul Weiler and Jim Medford, Back on Track: The Principles of Corrective Justice for 
Performance Enhancing Malpractice in Sports, SSRN (Oct. 27, 2007), 
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1020302. 
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whether any elements of his model can be transposed into solving correlative issues in 
performance enhancing malpractice.  
The analysis of Professor Weiler’s model included assessment of the “vulnerable 
stakeholders in the medical malpractice system,” as well as the proposition that traditional 
personal liability of individual physicians needs to be replaced by a new full-blown enterprise 
liability of health care organizations.  It was followed by the proposal that it was necessary for 
the responsible organization in the medical malpractice context to create an internal peer review 
committee as one of its quality assurance programs.  Lastly, the model stated that to bring 
malpractice reform even further would require a radical move from fault to no-fault liability, 
which would treat injured patients in the same fashion as injured nurses.   
Summing up, three pillars of Professor Weiler’s proposed medical malpractice reform are 
enterprise liability of the health care organization for the wrongdoing of doctors, a peer review 
system implemented by the health care organization, and no-fault liability for the injured 
patients. These pillars redefine the respective position of the parties and would restore the 
notional equality with which the parties enter the transaction when they seek treatment.  We had 
then examined whether any of these principles can be transposed to performance enhancing 
malpractice and, as we will show, it is feasible to apply two out of three elements in this new 
context.  
Unlike in medical malpractice where the injuries are often the result of the high-risk 
medical profession in which the doctors commit the wrong unintentionally; the athletes usually, 
but not always, resort to taking performance-enhancing substances by their own choice.  
Unfortunately, the current testing is not risk free and innocent victims can become implicated in 
the doping scandals.  Obviously, the testing has to keep up with and preferably keep ahead of 
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science but, given these risks, it is feasible that other bodies, such as the sports organizations, 
should step in to bear the risk of the process, which is not free of wrongful convictions. Though 
admittedly the wrongful convictions are rare, the effects on wrongly convicted individuals are 
profound. These are reasons why enterprise liability, which was also introduced in the medical 
malpractice model, should apply in the present context.  
The theory of enterprise liability, according to Gregory C. Keating, “asserts “that (1) 
accident costs should be internalized by the activity responsible for them; and (2) accident costs 
should be dispersed and distributed among the participants in that activity. This idea can be 
incarnated by strict liability in tort, but it can also be incarnated in other ways.  Indeed, enterprise 
liability first appears in Worker’s Compensation schemes enacted early in the twentieth century. 
Enterprise liability in tort generally involves imposing strict liability on injurers, but its aim can 
also be affected by mandatory loss insurance.  Compulsory loss insurance spreads an activity’s 
accident cost among all the potential victims of an activity, each of whom pays a premium to 
spread his or her share of the risk.”43   
However, this enterprise liability model would differ from the medical malpractice in that 
it would continue applying the current strict liability regime rather than the no-fault regime.  The 
enterprise liability would require sports organizations to underwrite compulsory loss insurance in 
order to generate funds aimed for professional rehabilitation of athletes.  
 
VI. Feasibility of the Proposed Model  
Naturally, the issue arises whether this well-intended model is subject to abuse by 
repeated wrongdoers and it raises concern about the risk of anti-selection.  In the insurance 
world, anti-selection occurs when high-risk individuals purchase more insurance than those with 
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normal-risk exposure.  This could lead to an overall premium increase in order for insurers to 
protect themselves. 
44
 
We believe that though there is such a risk, the loss of endorsements, faith and the moral 
stigma associated with doping are factors that will give disincentive for abuse of this model.  The 
policy principle, which we seek to achieve, is to protect innocent victims from wrongful 
convictions and “put back on track” a broad population of athletes.  Clearly, in order to achieve 
the deterrence aspect, the endorsement insurance should not be available to repeated wrongdoers.  
In addition, to give a disincentive for athletes to rely on the insurance and engage in 
performance enhancing malpractice, each sport federation could set up an internal peer review 
committee.  The funds would be payable to the committee in trust for the athlete who is in the 
process of rehabilitation.  This system will provide impetus for the sports organization to be 
more vigilant and internally manage/suppress any suspicion of the doping activity at its root.  
To be eligible for this income, the athlete will need to cooperate with the peer review 
committee, truly disclose the circumstances of the doping offense and spend a number of hours 
in community service.  The peer review committee will be constituted by two members 
appointed by the federation and one member designated by the athlete and will also provide 
emotional support and monitor the come-back of the athlete.  
In addition, individual sport federations/organizations may also choose to negotiate a 
short-term disability insurance that would pay for living expenses during the suspension, but this 
would have to be explored separately.  It also seems to be the case, that if we want the athletes 
and sports organizations to be covered by certain insurance policies, we need to steer away from 
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classifying the performance enhancing malpractice as criminal or quasi-criminal, and treat them 
more like “sui generis” offenses.  
In addition, the insurance companies can assume a more active role and have more 
control over the process.  The time may be ripe for insurers to reach beyond their traditional roles 
in relation to sports.  “Over the years, insurance institutions have been a significant force in the 
development and dissemination of harm-reducing technologies and practices.” 45 This 
involvement of insurance companies in testing and developing new technologies did not happen 
randomly, but this trend is rooted in the core function of insurance institutions, which is harm 
prevention.  “It is not uncommon for insurance companies to test and rate the crashworthiness of 
cars or to establish the underwriter’s labs to test materials for resistance to fire and other 
hazards.”46  
As such, the insurers who would underwrite specialized insurance for the sports 
organizations/federations to cover athletes’ expenses during their doping suspensions, may be 
more motivated to become involved in risk prevention – developing more accurate doping 
control systems.  This would bring added value, not only for the parties involved, but also to 
society in general because more precise testing would reduce the risk of wrongful suspensions. 
However, even if the insurers and sports federations would be willing to consider such a 
new model, we need to ask ourselves whether such a system would not be contradictory to the 
deterrence objective of the doping suspensions.  
First, this support model will not be available to permanently suspended athletes who are 
repeat offenders because this type of relief only provides a temporary means of support.  In 
addition, the athletes who will benefit from this assistance will ultimately have to pay their dues 
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back when they reenter the competition and negotiate their insurance policies. As part of 
negotiating the insurance policy, they will have to disclose their history of doping, which will 
result in paying higher insurance premiums. 
 
VII. Conclusion 
As we are gearing up for the 2012 Summer London Olympics and future international 
sporting events, the organizers of theses events spend great effort and resources to educate the 
athletes by launching “win clean campaigns”47 and other measures. The issue of assisting 
athletes who engage or are accused of engaging in performance enhancing malpractice is also a 
moral question about whether our society wants to assist individuals who presumably compete 
unfairly, in order to gain advantage over others and receive undeserving glory.  There is an 
aspect of paternalism in providing a helping hand to these individuals.  However, this proposed 
corrective model is not imposed or mandated. It is up to each sport’s organization/federation to 
consider its applicability to their particular sport, culture and region and adopt it in conjunction 
with the specialty insurance providers, which would best serve their needs. 
Our societies seek to provide a system of support and rehabilitation for all types of 
morally reprehensible forms of conduct.  There is no reason for not providing it for those who 
engage in performance enhancing malpractice.  There are many athletes who regret their bad 
decisions and wish “to come back on track”, compete, inspire others who are outside of the field 
of sports, and also hope for a second chance.  
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